320 related articles for article (PubMed ID: 21517111)
1. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic analysis of esophageal squamous cell carcinoma.
Qi Y; Chiu JF; Wang L; Kwong DL; He QY
Proteomics; 2005 Jul; 5(11):2960-71. PubMed ID: 15986332
[TBL] [Abstract][Full Text] [Related]
5. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma.
Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS
Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
7. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.
Du XL; Hu H; Lin DC; Xia SH; Shen XM; Zhang Y; Luo ML; Feng YB; Cai Y; Xu X; Han YL; Zhan QM; Wang MR
J Mol Med (Berl); 2007 Aug; 85(8):863-75. PubMed ID: 17318615
[TBL] [Abstract][Full Text] [Related]
9. Identification and expression of a tumor-associated antigen in esophageal squamous cell carcinoma.
Gao HJ; Yue ZG; Zheng M; Zheng ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):244-8. PubMed ID: 22776657
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis.
Yu SB; Gao Q; Lin WW; Kang MQ
Mol Med Rep; 2017 Mar; 15(3):1236-1242. PubMed ID: 28138712
[TBL] [Abstract][Full Text] [Related]
11. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.
Li X; Zheng S; Liu Q; Liu T; Liang M; Gao X; Lu M; Sheyhidin I; Lu X
Mol Carcinog; 2015 Sep; 54(9):779-88. PubMed ID: 24668792
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas.
Hu H; Luo ML; Du XL; Feng YB; Zhang Y; Shen XM; Xu X; Cai Y; Han YL; Wang MR
Chin Med J (Engl); 2007 Dec; 120(23):2092-8. PubMed ID: 18167182
[TBL] [Abstract][Full Text] [Related]
13. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
[TBL] [Abstract][Full Text] [Related]
14. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang.
Liu Z; Feng JG; Tuersun A; Liu T; Liu H; Liu Q; Zheng ST; Huang CG; Lv GD; Sheyhidin I; Lu XM
Mol Biol Rep; 2011 Jun; 38(5):3261-9. PubMed ID: 21125333
[TBL] [Abstract][Full Text] [Related]
16. Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma.
Ren P; Ye H; Dai L; Liu M; Liu X; Chai Y; Shao Q; Li Y; Lei N; Peng B; Yao W; Zhang J
Oncol Rep; 2013 Nov; 30(5):2297-303. PubMed ID: 24009050
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
19. Identification of proteomic signatures associated with lung cancer and COPD.
Pastor MD; Nogal A; Molina-Pinelo S; Meléndez R; Salinas A; González De la Peña M; Martín-Juan J; Corral J; García-Carbonero R; Carnero A; Paz-Ares L
J Proteomics; 2013 Aug; 89():227-37. PubMed ID: 23665002
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
